Clinical Trial Update: Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing enzalutamide to standard androgen deprivation therapy in hormone-sensitive prostate cancer has completed and posted results. The study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-04-27